Clinicians' Views of Hepatitis C Virus Treatment Candidacy With Direct-Acting Antiviral Regimens for People Who Inject Drugs
Clicks: 213
ID: 268530
2016
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
6.3
/100
21 views
21 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
A cure is now the norm in HCV treatment, and there is an increasing need to address the barriers to treating PWID, the population with the highest burden of infection. Understanding treatment candidacy assessments is essential to improving uptake. This study provides insight into how clinicians view …
| Reference Key |
ak2016substanceclinicians'
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Asher AK;Portillo CJ;Cooper BA;Dawson-Rose C;Vlahov D;Page KA;; |
| Journal | substance use & misuse |
| Year | 2016 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
humans
pubmed abstract
nih
national institutes of health
national library of medicine
substance abuse
intravenous
hepatitis c*
carmen j portillo
hepacivirus
Antiviral Agents
pmid:27219274
PMC6907073
doi:10.3109/10826084.2016.1161054
Alice K Asher
Kimberly A Page
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.